𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemotherapy in head and neck cancer with bleomycin, cisplatinum, and methotrexate

✍ Scribed by T. Deitmer; D. Urbanitz

Book ID
112295127
Publisher
Springer-Verlag
Year
1988
Tongue
English
Weight
225 KB
Volume
114
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Chemotherapy of head and neck cancer: Co
Chemotherapy of head and neck cancer: Combination treatment with cyclophosphamide, adriamycin, methotrexate, and bleomycin
✍ Wittes, Robert E. ;Spiro, Ronald H. ;Shah, Jatin ;Gerold, Frank P. ;Koven, Berna πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 English βš– 470 KB πŸ‘ 1 views

## Abstract A combination of cyclophosphamide, adriamycin, methotrexate, and bleomycin (CAMB) was explored in patients with advanced, nonresectable epidermoid carcinoma from primary sites in the head and neck, recurrent or persistent after radiation or surgery. Objective regression (greater than 50

Chemotherapy for head and neck cancer. C
Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate
✍ Stephen D. Williams; Enrique Velez-Garcia; Issac Essessee; Gary Ratkin; Robert B πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 575 KB

One hundred ninety-one patients with recurrent or metastatic squamous cell carcinoma of head and neck origin were allocated at random to chemotherapy with conventional-dose weekly intravenous methotrexate or the combination of cisplatin, vinblastine, and bleomycin. Methotrexate induced responses in

Multidrug chemotherapy using bleomycin,
Multidrug chemotherapy using bleomycin, methotrexate, and cisplatin combined with radical radiotherapy in advanced head and neck cancer
✍ Dr. J. Zidan; A. Kuten; Y. Cohen; E. Robinson πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 266 KB πŸ‘ 2 views

Thirty-one patients with Stage III-IV head and neck squamous cell cancer were treated by three courses of combination chemotherapy using bleomycin, methotrexate, and cisplatin followed by a radical course of radiation and in two cases by surgery. Of 29 evaluable patients, 4 (14%) achieved complete r